Dermata Therapeutics Inc. Gains 44%

Mon, Mar 21, 2022 at 05:30 PM
Dermata Therapeutics Inc. Gains 44%

Dermata Therapeutics Inc. (DRMA:NASDAQ) soared at $1.44, a gain of 44%. On Fri, Mar 18, 2022, DRMA:NASDAQ hit a New 2-Week Intraday High of $1.12. From Mon, Mar 07, 2022, the stock recorded 44.44% Up Days and 20.00% Green Days

The stock spiked on Wed, Nov 03, 2021 at $6.95 with a volume of 4M+.

About Dermata Therapeutics Inc. (DRMA:NASDAQ)

Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.